Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,824 | -734 | -10,278 | -9,395 | -6,017 |
| Depreciation Amortization | 313 | 133 | 922 | 285 | 156 |
| Accounts payable and accrued liabilities | 116 | 112 | -2,135 | -1,466 | -654 |
| Other Working Capital | 926 | 150 | -17,446 | -13,987 | -8,427 |
| Other Operating Activity | 1,693 | 110 | 5,856 | 6,442 | 2,849 |
| Operating Cash Flow | $1,224 | $-229 | $-23,081 | $-18,121 | $-12,093 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 3,151 | 1,149 | 1,150 |
| Financing Cash Flow | $N/A | $N/A | $3,151 | $1,149 | $1,150 |
| Beginning Cash Position | 4,327 | 4,327 | 49,317 | 49,317 | 49,317 |
| End Cash Position | 5,232 | 4,338 | 4,327 | 10,166 | 13,729 |
| Net Cash Flow | $905 | $11 | $-44,990 | $-39,151 | $-35,588 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,224 | -229 | -23,081 | -18,121 | -12,093 |
| Free Cash Flow | 1,224 | -229 | -23,081 | -18,121 | -12,093 |